Royal Bank of Canada vs Smith & Nephew plc — how do they compare? Royal Bank of Canada trades at $210.37 (market cap $289.51B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Royal Bank of Canada is far larger — about 22.9× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.57%). Which is the better fit depends on your goals.
| RY | SNN | |
|---|---|---|
Market Cap | $289.51B | $12.64B |
Sector | Financials | Health |
52-Week High | $217.87 | $38.70 |
52-Week Low | $128.46 | $28.73 |
Dividend Yield | 2.42% | 2.57% |
Enterprise Value | — | $15.41B |
Trailing returns across standard periods
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →